MedPath
Found 1 clinical trials|View Analysis
Sort by:

Study of Intramyocardial Injection of Ventrix Bio Extracellular Matrix (VentriGel) to Assess the Safety and Feasibility in Pediatric Patients With Hypoplastic Left Heart Syndrome (HLHS)

Phase 1
Not yet recruiting
Conditions
Hypoplastic Left Heart Syndrome
Interventions
Drug: Ventrix Bio Extracellular Matrix
First Posted Date
2024-06-17
Last Posted Date
2024-06-17
Lead Sponsor
Emory University
Target Recruit Count
12
Registration Number
NCT06461676
Locations
🇺🇸

Children's Healthcare of Altanta, Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath